Publications

Shafrin, Jason, Howard H. Z. Thom, Edna Keeney, Daisy M. Gaunt, Lauren M. Zhao, Menaka Bhor, Avery A. Rizio, Lanetta Bronté-Hall, and Nirmish Shah. “The impact of vaso-occlusive crises and disease severity on quality of life and productivity among patients with sickle cell disease in the US.” Curr Med Res Opin, March 27, 2021, 1–19. https://doi.org/10.1080/03007995.2021.1897556.

PMID
33686891
Full Text

Panaggio, Mark J., Daniel M. Abrams, Fan Yang, Tanvi Banerjee, and Nirmish R. Shah. “Can subjective pain be inferred from objective physiological data? Evidence from patients with sickle cell disease.” Plos Comput Biol 17, no. 3 (March 2021): e1008542. https://doi.org/10.1371/journal.pcbi.1008542.

PMID
33705373
Full Text

Al-Samkari, Hanny, Kathryn Addonizio, Bertil Glader, D Holmes Morton, Satheesh Chonat, Alexis A. Thompson, Kevin H. M. Kuo, et al. “The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.” Br J Haematol 192, no. 6 (March 2021): 1092–96. https://doi.org/10.1111/bjh.16724.

PMID
32463523
Full Text

Haykal, Tarek, Soheir Adam, Areeg Bala, Yazan Zayed, Smit Deliwala, Josiane Kerbage, Anoosha Ponnapalli, Srikanth Malladi, Varun Samji, and Thomas L. Ortel. “Thromboprophylaxis for orthopedic surgery; An updated meta-analysis.” Thromb Res 199 (March 2021): 43–53. https://doi.org/10.1016/j.thromres.2020.12.007.

PMID
33422802
Full Text

Federspiel, Jerome J., Lauren E. Wein, Kateena L. Addae-Konadu, Kristin C. Darwin, Laura E. Talamo, Evan R. Myers, and Andra H. James. “Venous thromboembolism incidence among patients recommended for pharmacologic thromboembolism prophylaxis after cesarean delivery in selected guidelines.” J Thromb Haemost 19, no. 3 (March 2021): 830–38. https://doi.org/10.1111/jth.15218.

PMID
33345404
Full Text

Niss, O., R. B. Lorsbach, M. Berger, S. Chonat, M. McLemore, D. Buchbinder, T. McCavit, et al. “Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR) (Accepted).” Blood Cells, Molecules, and Diseases 87 (March 1, 2021). https://doi.org/10.1016/j.bcmd.2020.102534.

Full Text

Niss, O., R. B. Lorsbach, M. Berger, S. Chonat, M. McLemore, D. Buchbinder, T. McCavit, et al. “Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR) (Accepted).” Blood Cells, Molecules, and Diseases 87 (March 1, 2021). https://doi.org/10.1016/j.bcmd.2020.102534.

Full Text

Niss, Omar, Robert B. Lorsbach, Mikaela Berger, Satheesh Chonat, Morgan McLemore, David Buchbinder, Timothy McCavit, et al. “Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).” Blood Cells Mol Dis 87 (March 2021): 102534. https://doi.org/10.1016/j.bcmd.2020.102534.

PMID
33401150
Full Text

Stewart, Kearsley A., Monika Parshad-Asnani, Ambroise Wonkam, John Bollinger, Valentina Ngo Bitoungui, Edmond Wonkam-Tingang, Jill Powell, et al. “"Pain is Subjective": A Mixed-Methods Study of Provider Attitudes and Practices Regarding Pain Management in Sickle Cell Disease Across Three Countries.” J Pain Symptom Manage 61, no. 3 (March 2021): 474–87. https://doi.org/10.1016/j.jpainsymman.2020.08.029.

PMID
32889040
Full Text

Evans, Brooke A., Andrea K. Ansari, Reed W. Kamyszek, Michele Salvagno, John Welsby, Matthew Fuller, and Ian Welsby. “Modulation of red blood cell oxygen affinity with a novel allosteric modifier of hemoglobin is additive to the Bohr effect.” Blood Cells Mol Dis 87 (March 2021): 102520. https://doi.org/10.1016/j.bcmd.2020.102520.

PMID
33242840
Full Text

Pages